KYTX NASDAQ
Kyverna Therapeutics, Inc.
1W: -6.8%
1M: -17.4%
3M: -20.4%
YTD: -35.8%
1Y: -24.3%
$5.63
+0.36 (+6.83%)
Weekly Expected Move ±7.5%
$5
$5
$5
$6
$6
Credit Risk of going bust: higher than 69% of companies Debt: 8.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99%), Kyverna Therapeutics, Inc. would be worth roughly what it owes.
Total debt $33.0M against a stock market value of $348.2M.
Distance to default 3.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $12.4M (short-term plus half of long-term), stock volatility 90.2%; Altman Z'' -3.38. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.07 (down 99%), Kyverna Therapeutics, Inc. would be worth roughly what it owes.
Total debt $33.0M against a stock market value of $348.2M.
Distance to default 3.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $12.4M (short-term plus half of long-term), stock volatility 90.2%; Altman Z'' -3.38. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-03-27
Earliest Filing
2025-03-27
Latest Filing
partner: 1
Counterparties (Filed by KYTX)
1 relationshipsCompanies named in KYTX's SEC 8-K filings as business counterparties.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-24 | Regulation FD; Exhibits | View | |
| 2026-08-11 | Earnings Release; Exhibits | View | |
| 2026-07-27 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-07-09 | Material Agreement; Exhibits | Agreement | View |
| 2026-06-02 | Shareholder Vote; Exhibits | View | |
| 2026-05-18 | Officer/Director Change; Other Events; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-05-04 | Other Events; Exhibits | View | |
| 2026-04-22 | Regulation FD; Exhibits | View | |
| 2026-04-22 | Regulation FD; Exhibits | View | |
| 2026-04-20 | Regulation FD; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-02-24 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2026-02-03 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-12-18 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-12-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-03 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Regulation FD Dis | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR